4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-23-006742
President and CEO acquired 238,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2023-02-28 | Grant or award | +238,750 | 1,455,285 | D | ||
| Derivatives | |||||||
| Brady Todd C President and CEO | 2023-02-28 | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | D | ||
Loading xslF345X03/doc4.xml…